u/Inside_Guava_5482

I do own this with less than 10,000 shares.

APR LOOKS like it is about 220% cost to Borrow this morning with Hard to Borrow status at all Brokers.

This ran 3000% in 2021 on Phase results & wasn’t shorted anything like this.

Phase 3 due any day Plus insiders own 53% of the stock and they have it locked up.

Very few opportunities like this and could RUN organically as it is an Index fund.

Wild.

I do own less than 50,000 shares and will add more as price continues to go up.

APR LOOKS like it is about 110% cost to Borrow with Hard to Borrow status at all Brokers.

I own less than 10,000 shares. Will add.

This ran 3000% in 2021 on Phase results & wasn’t shorted anything like this.

Phase 3 due any day Plus insiders own 53% of the stock and they have it locked up.

Very few opportunities like this and could RUN organically as it is an Index fund.

Wild.

I do own less than 50,000 shares and will add more as price continues to go up.

What does everyone think since The Claude Portfolio added last week?

It’s the smallest by far in terms of m/c yet comprises almost 7% of its portfolio.

I’ve owned this for years and it’s up since it was under $1 on a FDA CRL.

It’s really good momentum with Insider Buys and David Mott is the Chairman w experience in M&A.

Big Options last week indicated Call Volume up.